Advisor Partners’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
OCBV
Advisor Partners's RMD Position: Q2 2022 in Review
Advisor Partners increased its ResMed (RMD) stake by 74% in Q2 2022, buying an estimated $484K and bringing the position to 5,347 shares worth $1.12M. The position accounts for 0.08% of the portfolio, ranked #266.
Advisor Partners first reported a position in RMD in Q4 2017 and has held it in 18 quarters since. 677 funds tracked by Wall St. Rank hold RMD as of Q2 2022.
- Advisor Partners held 5,347 shares of ResMed worth $1.12M as of Q2 2022.
- Advisor Partners bought 2,272 ResMed shares in Q2 2022, an estimated $484K.
- ResMed made up 0.08% of Advisor Partners's portfolio in Q2 2022, its #266 holding.
- Advisor Partners first reported a position in ResMed in Q4 2017 and has held it in 18 quarters since.
- 677 funds tracked by Wall St. Rank held ResMed as of Q2 2022.
Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.